In this study we have described an hiPSC-CM model of ARVC derived from a patient with a novel pathogenic mutation in DSG2 and demonstrated a distinct phenotype with altered DSG2 expression, enhanced inflammatory signaling, and electrophysiological aberrations compared with controls. Here, DSG2 is linked to Arrhythmogenic right ventricular dysplasia.